Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

6:06 PM ET Form 4
Insider Selling Alphabet Inc. GOOGL

Alphabet Director Frances Arnold Sells $28.3K of Stock

Frances Arnold, Director, sold 83 shares of Alphabet Inc. at $340.45 a share, worth $28.3K in total on Sep 30, 2026. Shares held after the trade: 19,076 (-0.4%).

Value
$28.3K
Shares
83
Price
$340.45
Role
Director
Holding change
-0.4%
Trade date
Sep 30, 2026
6:03 PM ET Form 4
Insider Selling PennyMac Mortgage Investment Trust PMT

PennyMac Mortgage Investment Trust CAO Gregory L. Hendry Sells $19.2K of Stock

Gregory L. Hendry, CAO, sold 2,444 shares of PennyMac Mortgage Investment Trust at $7.86 a share, worth $19.2K in total on Oct 1, 2026. Shares held after the trade: 4,886 (-33.3%).

Value
$19.2K
Shares
2,444
Price
$7.86
Role
CAO
Holding change
-33.3%
Trade date
Oct 1, 2026
5:55 PM ET Form 4
Insider Selling Roblox Corp RBLX

Roblox Insider Gregory Baszucki Sells $714K of Stock

Gregory Baszucki sold 16,666 shares of Roblox Corp at $42.57 to $43.03 a share (average $42.87) in 4 transactions, worth $714K in total on Oct 1, 2026. Shares held after the trade: 1,252,836 (-0.4%).

Value
$714K
Shares
16,666
Average price
$42.87
Holding change
-0.4%
Trade date
Oct 1, 2026
5:53 PM ET Form 4
Insider Selling Mineralys Therapeutics, Inc. MLYS

Mineralys Therapeutics CEO Jon Congleton Sells $1.91M of Stock

Jon Congleton, CEO, sold 75,000 shares of Mineralys Therapeutics, Inc. at $25.46 a share, worth $1.91M in total on Sep 30, 2026. Shares held after the trade: 528,621 (-12.4%).

Value
$1.91M
Shares
75,000
Price
$25.46
Role
CEO
Holding change
-12.4%
Trade date
Sep 30, 2026
5:51 PM ET Form 4
Insider Selling Rivian Automotive, Inc. RIVN

Rivian Automotive Chief Administrative Officer Michael John Callahan Sells $225K of Stock

Michael John Callahan, Chief Administrative Officer, sold 15,000 shares of Rivian Automotive, Inc. at $15.00 a share, worth $225K in total on Oct 1, 2026. Shares held after the trade: 1,001,776 (-1.5%).

Value
$225K
Shares
15,000
Price
$15.00
Role
Chief Administrative Officer
Holding change
-1.5%
Trade date
Oct 1, 2026
5:51 PM ET Form 4
Insider Selling Oric Pharmaceuticals, Inc. ORIC

Oric Pharmaceuticals Director Richard A. Heyman Sells $86.5K of Stock

Richard A. Heyman, Director, sold 6,700 shares of Oric Pharmaceuticals, Inc. at $12.91 a share, worth $86.5K in total on Oct 1, 2026. Shares held after the trade: 203,472 (-1.5%).

Value
$86.5K
Shares
6,700
Average price
$12.91
Role
Director
Holding change
-1.5%
Trade date
Oct 1, 2026
5:50 PM ET Form 4
Insider Selling Rubrik, Inc. RBRK

Rubrik Director John Wendell Thompson Sells $1.56M of Stock

John Wendell Thompson, Director, sold 13,500 shares of Rubrik, Inc. at $114.68 to $116.47 a share (average $115.69) in 6 transactions, worth $1.56M in total on Oct 1, 2026. Shares held after the trade: 8,362 (-22.3%).

Value
$1.56M
Shares
13,500
Average price
$115.69
Role
Director
Holding change
-22.3%
Trade date
Oct 1, 2026
5:50 PM ET Form 4
Insider Selling Cactus, Inc. WHD

Cactus Chairman and CEO Scott Bender Sells $6.2M of Stock

Scott Bender, Chairman and CEO, sold 100,000 shares of Cactus, Inc. at $61.97 a share, worth $6.2M in total on Oct 1, 2026. Shares held after the trade: 120,527 (-45.3%).

Value
$6.2M
Shares
100,000
Price
$61.97
Role
Chairman and CEO
Holding change
-45.3%
Trade date
Oct 1, 2026
5:50 PM ET Form 4
Insider Selling Cactus, Inc. WHD

Cactus President Joel Bender Sells $6.2M of Stock

Joel Bender, President, sold 100,000 shares of Cactus, Inc. at $61.97 a share, worth $6.2M in total on Oct 1, 2026. Shares held after the trade: 41,519 (-70.7%).

Value
$6.2M
Shares
100,000
Price
$61.97
Role
President
Holding change
-70.7%
Trade date
Oct 1, 2026
5:48 PM ET Form 4
Insider Selling First Solar, Inc. FSLR

First Solar CTO Markus Gloeckler Sells $139K of Stock

Markus Gloeckler, CTO, sold 800 shares of First Solar, Inc. at $174.00 a share, worth $139K in total on Oct 1, 2026. Shares held after the trade: 5,042 (-13.7%).

Value
$139K
Shares
800
Price
$174.00
Role
CTO
Holding change
-13.7%
Trade date
Oct 1, 2026
5:48 PM ET Form 4
Insider Selling Anaptysbio, Inc ANAB

Anaptysbio Director Hollings Renton Sells $249K of Stock

Hollings Renton, Director, sold 5,000 shares of Anaptysbio, Inc at $49.87 a share, worth $249K in total on Oct 1, 2026. Shares held after the trade: 10,995 (-31.3%).

Value
$249K
Shares
5,000
Price
$49.87
Role
Director
Holding change
-31.3%
Trade date
Oct 1, 2026
5:42 PM ET Form 4
Insider Buying CI&T Inc CINT

CI&T Insider Fernando Matt Borges Martins Buys $13.1K of Stock

Fernando Matt Borges Martins bought 4,123 shares of CI&T Inc at $3.18 a share, worth $13.1K in total on Oct 1, 2026. Shares held after the trade: 4,123.

Value
$13.1K
Shares
4,123
Price
$3.18
Trade date
Oct 1, 2026
5:38 PM ET Form 4
Insider Selling Roivant Sciences Ltd. ROIV

Roivant Sciences President & Immunovant CEO Eric Venker Sells $7.32M of Stock

Eric Venker, President & Immunovant CEO, sold 200,000 shares of Roivant Sciences Ltd. at $36.62 a share, worth $7.32M in total on Sep 30, 2026. Shares held after the trade: 1,599,154 (-11.1%).

Value
$7.32M
Shares
200,000
Price
$36.62
Role
President & Immunovant CEO
Holding change
-11.1%
Trade date
Sep 30, 2026
5:37 PM ET Form 4
Insider Selling Stoke Therapeutics, Inc. STOK

Stoke Therapeutics General Counsel & Corp Sec Jonathan Allan Sells $16.5K of Stock

Jonathan Allan, General Counsel & Corp Sec, sold 627 shares of Stoke Therapeutics, Inc. at $26.33 a share, worth $16.5K in total on Oct 2, 2026. Shares held after the trade: 20,598 (-3.0%).

Value
$16.5K
Shares
627
Price
$26.33
Role
General Counsel & Corp Sec
Holding change
-3.0%
Trade date
Oct 2, 2026
5:36 PM ET Form 4
Insider Selling Stoke Therapeutics, Inc. STOK

Stoke Therapeutics CMO Barry Ticho Sells $27.5K of Stock

Barry Ticho, CMO, sold 1,051 shares of Stoke Therapeutics, Inc. at $26.16 a share, worth $27.5K in total on Oct 1, 2026. Shares held after the trade: 19,059 (-5.2%).

Value
$27.5K
Shares
1,051
Price
$26.16
Role
CMO
Holding change
-5.2%
Trade date
Oct 1, 2026
5:34 PM ET Form 4
Insider Selling Walmart Inc. WMT

Walmart EVP Daniel J. Bartlett Sells $417K of Stock

Daniel J. Bartlett, EVP, sold 3,990 shares of Walmart Inc. at $104.41 a share, worth $417K in total on Oct 1, 2026. Shares held after the trade: 618,359 (-0.6%).

Value
$417K
Shares
3,990
Price
$104.41
Role
EVP
Holding change
-0.6%
Trade date
Oct 1, 2026
5:31 PM ET Form 4
Insider Selling Cardlytics, Inc. CDLX

Cardlytics CEO Amit Gupta Sells $46.7K of Stock

Amit Gupta, CEO, sold 17,733 shares of Cardlytics, Inc. at $2.53 to $2.71 a share (average $2.64) in 2 transactions, worth $46.7K in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 138,906 (-5.0%).

Value
$46.7K
Shares
17,733
Average price
$2.64
Role
CEO
Holding change
-5.0%
Trade date
Oct 1, 2026 to Oct 2, 2026
5:29 PM ET 8-K
Shareholder Meeting Outdoor Holding Co POWW

Outdoor Holding Shareholder Meeting

Outdoor Holding Company held its 2026 Annual Meeting of Stockholders on September 28, 2026, where shareholders approved the redomestication of the company from Delaware to Texas. The conversion became effective on September 30, 2026, resulting in the company's internal affairs being governed by Texas law and the automatic conversion of outstanding common and preferred shares into shares of the new Texas corporation.

5:28 PM ET 8-K
Divestiture ChronoScale Holdings Corp CHRN

ChronoScale Holdings Divestiture

ChronoScale Holdings Corporation completed the sale of its wholly owned subsidiary, Ekso Bionics, Inc., to focus resources on its core AI infrastructure business. In connection with the divestiture, Ekso's COO Jason C. Jones was terminated and received a severance package totaling approximately $0.24 million. The company also announced new AI infrastructure contracts expected to drive an annualized revenue run rate of $1 billion by Q3 2027.

5:25 PM ET 8-K
Shareholder Meeting Richtech Robotics Inc. RR

Richtech Robotics Shareholder Meeting

Richtech Robotics Inc. held its 2026 Annual Meeting of Stockholders on September 29, 2026. Shareholders elected Saul Factor and John Shigley to the Board of Directors for three-year terms and ratified the appointment of CBIZ CPAs P.C. as the company's independent auditor.

5:21 PM ET Form 4
Insider Selling Nurix Therapeutics, Inc. NRIX

Nurix Therapeutics CLO Christine Ring Sells $134K of Stock

Christine Ring, CLO, sold 5,786 shares of Nurix Therapeutics, Inc. at $23.19 a share, worth $134K in total on Oct 2, 2026. Shares held after the trade: 9,110 (-38.8%).

Value
$134K
Shares
5,786
Price
$23.19
Role
CLO
Holding change
-38.8%
Trade date
Oct 2, 2026
5:20 PM ET 8-K
Court & Legal Update Tonix Pharmaceuticals Holding Corp. TNXP

Tonix Pharmaceuticals Holding Court & Legal Update

Tonix Pharmaceuticals received a Paragraph IV patent certification notice from Dr. Reddy’s Laboratories (DRL) regarding an Abbreviated New Drug Application (ANDA) for a generic version of TONMYA®. DRL claims that four of Tonix's Orange Book-listed patents are invalid, unenforceable, or not infringed. Tonix intends to vigorously enforce its intellectual property rights, which could trigger an automatic 30-month stay of FDA approval for the generic product.

Counterparty
Dr. Reddy’s Laboratories Ltd. and Dr. Reddy’s Laboratories, Inc.
5:20 PM ET 8-K
Nasdaq/NYSE Compliance Notice Healthcare Triangle, Inc. HCTI

Healthcare Triangle Nasdaq/NYSE Compliance Notice

Healthcare Triangle received a Staff Delisting Determination from Nasdaq on October 1, 2026, for failing to maintain the $1.00 minimum bid price requirement. Because the company has already effected cumulative reverse stock splits exceeding a 1-for-250 ratio over the last two years, it is ineligible for a standard 180-day compliance period. The company intends to appeal the delisting determination to a Nasdaq Hearings Panel, which will stay the suspension of its common stock pending a decision.

Counterparty
Nasdaq
5:20 PM ET Form 4
Insider Selling PTC Therapeutics, Inc. PTCT

PTC Therapeutics Director Glenn Steele Jr. Md. Phd. Sells $782K of Stock

Glenn Steele Jr. Md. Phd., Director, sold 12,000 shares of PTC Therapeutics, Inc. at $65.16 a share, worth $782K in total on Sep 30, 2026. Shares held after the trade: 22,500 (-34.8%).

Value
$782K
Shares
12,000
Price
$65.16
Role
Director
Holding change
-34.8%
Trade date
Sep 30, 2026
5:20 PM ET Form 4
Insider Selling Rocket Lab Corp RKLB

Rocket Lab CFO Adam C. Spice Sells $9.93M of Stock

Adam C. Spice, CFO, sold 140,157 shares of Rocket Lab Corp at $70.28 to $71.79 a share (average $70.82) in 3 transactions, worth $9.93M in total on Oct 1, 2026. Shares held after the trade: 1,155,967 (-1.3%).

Value
$9.93M
Shares
140,157
Average price
$70.82
Role
CFO
Holding change
-1.3%
Trade date
Oct 1, 2026
5:20 PM ET Form 4
Insider Selling Ceribell, Inc. CBLL

Ceribell CTO Raymond Woo Sells $119K of Stock

Raymond Woo, CTO, sold 4,887 shares of Ceribell, Inc. at $24.38 a share, worth $119K in total on Oct 1, 2026. Shares held after the trade: 203,118 (-2.3%).

Value
$119K
Shares
4,887
Price
$24.38
Role
CTO
Holding change
-2.3%
Trade date
Oct 1, 2026
5:19 PM ET Form 4
Insider Selling Oramed Pharmaceuticals Inc. ORMP

Oramed Pharmaceuticals CFO Avraham Gabay Sells $90.2K of Stock

Avraham Gabay, CFO, sold 20,000 shares of Oramed Pharmaceuticals Inc. at $4.51 a share, worth $90.2K in total on Oct 1, 2026. Shares held after the trade: 861,076 (-2.3%).

Value
$90.2K
Shares
20,000
Price
$4.51
Role
CFO
Holding change
-2.3%
Trade date
Oct 1, 2026
5:19 PM ET Form 4
Insider Selling Oramed Pharmaceuticals Inc. ORMP

Oramed Pharmaceuticals COO & Cbo Joshua Hexter Sells $135K of Stock

Joshua Hexter, COO & Cbo, sold 30,000 shares of Oramed Pharmaceuticals Inc. at $4.51 a share, worth $135K in total on Oct 1, 2026. Shares held after the trade: 1,328,130 (-2.2%).

Value
$135K
Shares
30,000
Price
$4.51
Role
COO & Cbo
Holding change
-2.2%
Trade date
Oct 1, 2026
5:19 PM ET Form 4
Insider Buying AMG BBH Asset-Backed Credit Fund, LLC BBASX

AMG BBH Asset-Backed Credit Fund Insider Neil Martin Hohmann Buys $90K of Stock

Neil Martin Hohmann bought 9,020 shares of AMG BBH Asset-Backed Credit Fund, LLC at $9.98 a share, worth $90K in total on Jul 1, 2026. Shares held after the trade: 4,510.

Value
$90K
Shares
9,020
Average price
$9.98
Trade date
Jul 1, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.